Ursofalk® 250 mg tabletten.    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-003141-10-BE
(EUCTR)
29/09/201426/09/2014Invloed van UDCA op fecale galzoutensamenstelling van IBD patiënten: piloot studie.Invloed van UDCA op fecale galzoutensamenstelling van IBD patiënten: piloot studie. Crohn's disease or colitis ulcerosa
MedDRA version: 17.1;Level: PT;Classification code 10009900;Term: Colitis ulcerative;System Organ Class: 10017947 - Gastrointestinal disorders
MedDRA version: 17.1;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Trade Name: UrsoFalk® 250 mg tabletten.
Product Name: UrsoFalk
INN or Proposed INN: ursodeoxycholic acid
Other descriptive name: URSODEOXYCHOLIC ACID
Ghent University HospitalNULLNot RecruitingFemale: yes
Male: yes
80Phase 4Belgium